The digital health world seems to be continuing its rapid growth where around 70 companies' funding results were announced during the second quarter od 2018, totaling to $2 billion.
Gene editing and gene therapy can delete disease-causing genes in order to treat specific diseases. But the skill to control unwanted genes is a point of concern, as it might cause severe side effects. A research team from Cardiff University and the University of Bath have devised a switch to control protein expression in mouse embryos, which could be used in human gene therapies in future.
Ddu is an advanced global e-business trading platform for cross-border medical commerce. We devote our efforts to breaking the industry barriers to finding clients, establishing cross-border trade and building communication channels. We also assist suppliers and buyers from all over the world to solidify international business and provide complete solutions.
Onitor Track is an advanced biometric, data-driven program which aids in weight loss. Onitor Track combines a personalized weight loss and nutrition program with a dual-positioned wearable via an app.
The research team claimed that the effectiveness of drugs depends on the time of administration on a personalized level. Their goal was to identify the biomarkers in blood to characterize the ‘internal time’ of an individual.
Using nanotechnology, the research team developed tiny platinum nanomotors to target Zika and microbeads to bind the virus. When they are added to a sample containing Zika, a 3D complex is formed which moves in the presence of hydrogen peroxide. This unique motion signal can be perceived using a smartphone by attaching it to a cost-effective optical device. The 3D Zika complex moves rapidly compared to the slower movement of other non-target viruses.
NHS Digital and NHS England together have devised a free NHS app to book GP appointments in a swifter and user-friendly way. This novel NHS app will be launched in December 2018, allowing patients to access their health records in a safe and secure manner.
This research study was conducted on 100,000 participants including both HIV and non-HIV patients, aged around 48 years on an average. The results were published in the Journal of the American Heart Association where the participants with higher levels of bilirubin had 76% risk for cardiovascular diseases as same as the group with the lower bilirubin levels.
In a major breakthrough in the medical field, one of the world’s most dreadful viruses could possibly treat deadly brain tumors (glioblastoma). The survival chance turned out to be better than expected especially for patients who were administered the genetically modified poliovirus.
Telemedicine services are gaining entry into Japanese hospitals. Royal Philips recently announced its deal with Showa University in Japan in order to launch the first telemedicine intensive care program (eICU) at Showa Koto Toyosu Hospital and Showa University Hospital. This program will reduce mortality rates and increase savings as well as case volume.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.